FidoCure®
FidoCure® is the leader in Precision Medicine for Canine Oncology.
About
Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer! FidoCure® is a Y Combinator company (Winter 2018). YC-listed status: Active.
- Website
- fidocure.com
- Location
- San Francisco, CA, USA; Palo Alto, CA, USA; Remote
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- FidoCure — Precision oncology platform for dogs using genomic testing to identify targeted cancer therapies beyond chemo and radiation. · Service
Links
- Y Combinator profileycombinator